Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Diabetes. May 15, 2024; 15(5): 923-934
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.923
Table 2 Changes in parameters after each treatment (mean ± SD)
Parameter
Group A
Group B
Group C
P value
FPG (mmol/L)6.37 ± 1.436.40 ± 1.266.14 ± 1.200.553
White blood cells8.84 ± 3.467.35 ± 1.7415.83 ± 1.3520.000
Neutrophils6.38 ± 3.664.97 ± 2.0013.10 ± 1.1220.000
Uric acid (µmol/L)298.74 ± 71.33294.61 ± 72.68282.76 ± 63.400.444
SBP (mmHg)126.37 ± 9.39123.07 ± 10.60124.27 ± 11.150.272
DBP (mmHg)75.23 ± 5.8473.76 ± 6.5073.91 ± 4.560.325
PCT (mmol/L)0.72 ± 0.950.36 ± 0.4510.05 ± 0.0720.000
HbA1c (%)6.74 ± 0.876.76 ± 0.726.81 ± 0.520.855
LDL (mmol/L)2.29 ± 0.482.27 ± 0.472.44 ± 0.460.141
HDL (mmol/L)0.83 ± 0.26 0.74 ± 0.240.77 ± 0.220.136
TG (mmol/L)2.63 ± 0.702.51 ± 0.822.57 ± 0.560.683
TC (mmol/L)4.47 ± 0.53 4.49 ± 0.704.43 ± 0.620.901
ABI0.76 ± 0.09 0.79 ± 0.080.81 ± 0.0820.032
TcPO2 (mmHg)35.56 ± 10.1346.32 ± 8.83148.19 ± 8.3520.000
Total amputations1.23 ± 1.140.63 ± 0.6310.16 ± 0.3720.000
Mortality rate4.84%0.00%0.00%0.102
Cardiovascular event rate8.06%0.00%10.00%20.020
Hospitalization rate62.90%26.32%15.45%20.000
Reamputation rate58.06%28.95%11.82%20.000
Major amputation rate69.35%31.58%136.40%20.000
Minor amputation rate53.23% 31.58%114.55%20.000
Heal rate14.52%65.79%189.09%20.000
Improve rate85.48% 36.84%110.91%20.000
Ulcer area (cm2)3.74 ± 2.042.68 ± 1.9611.77 ± 1.2120.000
Diabetic foot surgery class3.01 ± 0.642.08 ± 0.9211.49 ± 0.9620.000